Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.

about

Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.

Item

http://www.wikidata.org/entity/Q42373511

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@en

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@nl

type

Item

label

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@en

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@nl

prefLabel

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@en

Newly Characterized Murine Und ...... apy with Oncolytic HSV-1 M002.

@nl

P1476

Newly Characterized Murine Und ...... rapy with Oncolytic HSV-1 M002

@en

P2093

Blake P Moore

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Beierle

http://www.w3.org/2001/XMLSchema#string

Eric K Ring

http://www.w3.org/2001/XMLSchema#string

G Yancey Gillespie

http://www.w3.org/2001/XMLSchema#string

James M Markert

http://www.w3.org/2001/XMLSchema#string

Jianmei W Leavenworth

http://www.w3.org/2001/XMLSchema#string

Li Nan

http://www.w3.org/2001/XMLSchema#string

Rong Li

http://www.w3.org/2001/XMLSchema#string

Virginia M Kelly

http://www.w3.org/2001/XMLSchema#string

Xiaosi Han

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of childhood cancer

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors

Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.

Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.

Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database.

Immature myeloid cells and cancer-associated immune suppression.

Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

P304

27-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTO.2017.09.003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gregory K Friedman

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29034313

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

5633864

http://www.w3.org/2001/XMLSchema#string